UCL academic clinician awarded NIHR Global Health Professorship
5 August 2024
Respiratory medicine researcher and honorary consultant, Professor John Hurst, has been awarded a prestigious global health professorship by the National Institute of Health and Care Research (NIHR).
Professor John Hurst, an academic clinician specialising in respiratory medicine at UCL, is among seven academics to have been awarded a professorship. Researchers selected for NIHR global professorships receive five-year awards of up to £2 million. The award will enable Prof Hurst to carry out project ‘Mitigating Chronic Respiratory Disease through the lens of Multi-Morbidity’ - a study in partnership with the Federal University of Sao Carlos in Brazil, that tests better ways to diagnose and treat chronic respiratory disease in those living with other long-term conditions.
Professor Hurst said: “I’m really excited to be able to continue our international work in chronic respiratory disease, and grateful to the fantastic support from colleagues across our Faculty in the application process”.
NIHR Academy Dean, Professor Waljit Dhillo said: “I’m delighted to warmly welcome Professor Hurst and the six other exemplary researchers as the latest cohort of NIHR Global Research Professors. As leaders in their fields, these outstanding individuals will play a key role in improving the health and care of people around the world as well as developing early career researchers in their teams.”
Further information:
- Professor John Hurst academic profile
- UCL Division of Medicine
- NIHR news: Seven researchers awarded prestigious NIHR Global Health Professorships
AI, Smartphones and Lung Health: Breathless with Excitement
Over 600 million people worldwide live with long-term lung health problems such as asthma and chronic obstructive pulmonary disease (COPD). We urgently need better ways to diagnose and treat them. Artificial Intelligence (AI) has the potential to transform healthcare. Prof. John Hurst and Dr Luke Hale review how AI can improve the care of those living with asthma and COPD, including a smartphone platform under development for patients with these conditions: